[Clinical experiences with a new spasmolytic; methylphenylpentanic acid-N-methylpiperidyl-4'-ester of hydrogen fumarate].
D001649:Bile Duct Diseases; D001652:Bile Ducts; D002317:Cardiovascular Agents; D004952:Esters; D005650:Fumarates; D006859:Hydrogen; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010276:Parasympatholytics; D014570:Urologic Diseases
D002317:Cardiovascular Agents; D004952:Esters; D005650:Fumarates; D009125:Muscle Relaxants, Central; D010276:Parasympatholytics; D006859:Hydrogen
BILE DUCTS/diseases; MUSCLE RELAXANTS/therapeutic use; URINARY TRACT/diseases
Klinische Erfahrungen mit einem neuen Spasmolytikum; Methylphenylpentansäure-N-methylpiperidyl-4'-ester-hydrogenafumarat.